Skip to content

Augustine Therapeutics – AGT-100216

The Phase I trial will focus on safety, tolerability, and pharmacokinetics (how the drug moves through the body) in healthy volunteers. Phase I trials are a foundation of clinical research. They help determine whether a new drug is safe enough to move forward into studies involving people with the disease it’s intended to treat.

CMTA Strategy To Accelerate Research (CMTA-STAR) logo on a white background

Principal Investigator

Augustine Therapeutics

Therapy / Approach

Clinical Trial - Phase 1

Total CMTA-STAR Project Investment

Unknown

Active